These are just a few of the news stories inspired by Otsuka America Pharmaceutical, Inc. and Lundbeck’s February 2016 study on Major Depressive Disorder Symptoms.
Results from a new survey suggest that significant gaps exist in the treatment for adults in the U.S. with major depressive disorder (MDD). Sixty-one percent of adult survey respondents with major depressive disorder (MDD) – who reported taking their medication as prescribed – say they still deal with MDD symptoms at least weekly… Read more.
About 61% of patients who live with major depressive disorder (MDD) and say they take their medication as prescribed still experience symptoms at least weekly, according to the results of a recent survey by Harris Poll commissioned by Otsuka America Pharmaceutical and Lundbeck. The results are shedding light on the daily struggles of the approximately 15 million U.S. adults who are affected by the illness… Read more.
Recent survey results indicated nearly two-thirds of adults with major depressive disorder reported experiencing depressive symptoms at least once a week, despite taking medication as prescribed. “The symptoms of major depressive disorder can have a debilitating effect on all aspects of the lives of adults who suffer from the disease,” Gerald A. Maguire, MD, DFAPA, of the University of California, Riverside School of Medicine, said in a press release… Read more.